Accelerate Diagnostics Profit Margin 2006-2019 | AXDX
Current and historical gross margin, operating margin and net profit margin for Accelerate Diagnostics (AXDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Accelerate Diagnostics net profit margin as of March 31, 2019 is -1352.8%.
|Accelerate Diagnostics Annual Profit Margins
|Accelerate Diagnostics Quarterly Profit Margins
||Medical Instruments Manufacturing
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.